Prostate Cancer Clinical Trials in Chicago, IL

View the best 10 prostate cancer medical studies in Chicago, Illinois. Access promising new therapies by applying to a Chicago-based Prostate Cancer clinical trial.

Top rated prostate cancer clinical trials in Chicago, Illinois

Here are the top 10 medical studies for prostate cancer in Chicago, Illinois

Michael Bask Gill, B Sc

Last Reviewed: March 16th, 2024

LHRH Analogue +3 More

Hormone Therapy

Recruiting2 awardsPhase 3

This trial is testing whether two different drugs can extend the time before cancer progresses in men with recurrent prostate cancer.

Prednisone +2 More

Corticosteroid

Recruiting3 awardsPhase 2

This trial is testing a new cancer treatment for men with metastatic castration resistant prostate cancer. It is a 1:1:1 randomized open-label multicenter phase II study, which means that patients will be randomly assigned to one of three different treatment groups. The study will take place at multiple centers, and patients will be observed over the course of the trial.

Pembrolizumab +7 More

Checkpoint Inhibitor

Recruiting1 awardPhase 1 & 2

This trial will assess the safety and efficacy of pembrolizumab in combination with other drugs for treating patients with mCRPC. There will be nine cohorts in the study, each receiving different combinations of drugs. Outcome measures will be assessed individually for each cohort.

NanoKnife Procedure

Procedure

Recruiting1 award

This trial will study whether the NanoKnife System is a safe and effective treatment for localized prostate cancer in intermediate risk subjects.

Pembrolizumab +1 More

Checkpoint Inhibitor

Recruiting1 awardPhase 3

This trial will test whether a combination of two drugs is better than one of the drugs alone at treating prostate cancer that has spread and is resistant to hormone therapy.

Vanquish System

Procedure

Recruiting1 award

This trial will evaluate a new device to treat prostate cancer in men with intermediate-risk Gleason Grade Group 2.

TNFerade™ Biologic

Recruiting1 awardPhase 1

This trial will test different doses of TNFerade in combination with radiation to see which is the most effective at treating prostate cancer while also having the least side effects.

Intensity-Modulated Radiation Therapy (IMRT) +1 More

Radiation Therapy

Recruiting2 awardsPhase 3

This trial compares two types of radiation therapy to treat prostate cancer. Stereotactic body radiation therapy may work better than intensity-modulated radiation therapy.

HDR Brachytherapy +2 More

Brachytherapy

Recruiting1 awardPhase 1 & 2

This trial is testing a treatment for prostate cancer that has come back after prior radiotherapy, which involves the placement of a radioactive material in the affected area of the prostate temporarily, and then is subsequently removed using a minimally invasive technique. Participants will also receive external radiation for 5 weeks targeting the pelvis and giving a higher dose each day to the suspicious lymph nodes on PET scan.

ZEN-3694 +2 More

BET Bromodomain Inhibitor

Recruiting1 awardPhase 2

This trial is testing a combination of drugs to treat patients with prostate cancer that has spread and is resistant to hormone therapy. The drugs work in different ways to attack the cancer cells.

Popular filter options for prostate-cancer chicago trials

Phase 3 Clinical Trials

View 100 phase 3 medical studies.

Proton Beam Therapy

Radiation + Androgen Suppression for Prostate Cancer

Recruiting2 awardsPhase 3

Warrenville, Illinois

This trial will compare the effectiveness of two treatments for prostate cancer.

Cancer Vaccine

ProstAtak® Immunotherapy + Radiation for Prostate Cancer

Recruiting1 awardPhase 3

Chicago, Illinois

This trial is testing whether adding ProstAtak immunotherapy to radiation therapy can improve outcomes for patients with localized prostate cancer at high or intermediate risk for the disease coming back.

Proton Beam Therapy